Clinical Research Directory
Browse clinical research sites, groups, and studies.
Injectable Extended-Release Buprenorphine (XR-B) in a Correctional Setting: Qualitative Interviews
Sponsor: Lifespan
Summary
This qualitative study investigates the potential benefits and challenges of using a once-a-month injectable medication, known as extended-release buprenorphine (XR-B), to treat individuals with opioid use disorder (OUD) within a correctional setting. The research aims to understand if XR-B can be a feasible and effective alternative to the standard daily treatment and to identify which groups within the prison population may benefit the most from this treatment. In-depth interviews are conducted with incarcerated individuals and relevant stakeholders.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
25
Start Date
2023-07-01
Completion Date
2024-07-01
Last Updated
2024-04-09
Healthy Volunteers
Yes
Locations (1)
Rhode Island Department of Corrections
Cranston, Rhode Island, United States